207 related articles for article (PubMed ID: 30609312)
1. Cardiac Fibrotic Remodeling on a Chip with Dynamic Mechanical Stimulation.
Kong M; Lee J; Yazdi IK; Miri AK; Lin YD; Seo J; Zhang YS; Khademhosseini A; Shin SR
Adv Healthc Mater; 2019 Feb; 8(3):e1801146. PubMed ID: 30609312
[TBL] [Abstract][Full Text] [Related]
2. Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases.
Tian G; Ren T
Eur J Cell Biol; 2023 Jun; 102(2):151288. PubMed ID: 36696810
[TBL] [Abstract][Full Text] [Related]
3. A three-dimensional in vitro dynamic micro-tissue model of cardiac scar formation.
Occhetta P; Isu G; Lemme M; Conficconi C; Oertle P; Räz C; Visone R; Cerino G; Plodinec M; Rasponi M; Marsano A
Integr Biol (Camb); 2018 Mar; 10(3):174-183. PubMed ID: 29532839
[TBL] [Abstract][Full Text] [Related]
4. Engineered 3D Cardiac Fibrotic Tissue to Study Fibrotic Remodeling.
Sadeghi AH; Shin SR; Deddens JC; Fratta G; Mandla S; Yazdi IK; Prakash G; Antona S; Demarchi D; Buijsrogge MP; Sluijter JPG; Hjortnaes J; Khademhosseini A
Adv Healthc Mater; 2017 Jun; 6(11):. PubMed ID: 28498548
[TBL] [Abstract][Full Text] [Related]
5. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
6. Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices.
Galie PA; Westfall MV; Stegemann JP
Cardiovasc Pathol; 2011; 20(6):325-33. PubMed ID: 21306921
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor κB signaling.
Tian K; Liu Z; Wang J; Xu S; You T; Liu P
Transl Res; 2015 Mar; 165(3):374-86. PubMed ID: 25475987
[TBL] [Abstract][Full Text] [Related]
8. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis.
Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G
Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606
[TBL] [Abstract][Full Text] [Related]
9. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
Medzikovic L; Heese H; van Loenen PB; van Roomen CPAA; Hooijkaas IB; Christoffels VM; Creemers EE; de Vries CJM; de Waard V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562500
[TBL] [Abstract][Full Text] [Related]
10. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
11. Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy.
Yong KW; Li Y; Huang G; Lu TJ; Safwani WK; Pingguan-Murphy B; Xu F
Am J Physiol Heart Circ Physiol; 2015 Aug; 309(4):H532-42. PubMed ID: 26092987
[TBL] [Abstract][Full Text] [Related]
12. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies.
Liu M; López de Juan Abad B; Cheng K
Adv Drug Deliv Rev; 2021 Jun; 173():504-519. PubMed ID: 33831476
[TBL] [Abstract][Full Text] [Related]
13. Substrate stiffness modulates cardiac fibroblast activation, senescence, and proinflammatory secretory phenotype.
Felisbino MB; Rubino M; Travers JG; Schuetze KB; Lemieux ME; Anseth KS; Aguado BA; McKinsey TA
Am J Physiol Heart Circ Physiol; 2024 Jan; 326(1):H61-H73. PubMed ID: 37889253
[TBL] [Abstract][Full Text] [Related]
14. Limb-bud and Heart (LBH) mediates proliferation, fibroblast-to-myofibroblast transition and EMT-like processes in cardiac fibroblasts.
Wu A; Zhang L; Chen J; Li H; Yang P; Chen M; Liu Q
Mol Cell Biochem; 2021 Jul; 476(7):2685-2701. PubMed ID: 33666830
[TBL] [Abstract][Full Text] [Related]
15. BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca
Liu W; Wang X; Mei Z; Gong J; Huang L; Gao X; Zhao Y; Ma J; Qian L
Sci Rep; 2017 May; 7(1):1906. PubMed ID: 28507335
[TBL] [Abstract][Full Text] [Related]
16. Mechanical stimulation of induced pluripotent stem derived cardiac fibroblasts.
Bekedam FT; Smal R; Smit MC; Aman J; Vonk-Noordegraaf A; Bogaard HJ; Goumans MJ; De Man FS; Llucià-Valldeperas A
Sci Rep; 2024 Apr; 14(1):9795. PubMed ID: 38684844
[TBL] [Abstract][Full Text] [Related]
17. Increase in cellular cyclic AMP concentrations reverses the profibrogenic phenotype of cardiac myofibroblasts: a novel therapeutic approach for cardiac fibrosis.
Lu D; Aroonsakool N; Yokoyama U; Patel HH; Insel PA
Mol Pharmacol; 2013 Dec; 84(6):787-93. PubMed ID: 24085841
[TBL] [Abstract][Full Text] [Related]
18. Matrix stiffness controls cardiac fibroblast activation through regulating YAP via AT
Niu L; Jia Y; Wu M; Liu H; Feng Y; Hu Y; Zhang X; Gao D; Xu F; Huang G
J Cell Physiol; 2020 Nov; 235(11):8345-8357. PubMed ID: 32239716
[TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart.
Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C
Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077
[TBL] [Abstract][Full Text] [Related]
20. Role of the cytoskeleton in the development of a hypofibrotic cardiac fibroblast phenotype in volume overload heart failure.
Childers RC; Sunyecz I; West TA; Cismowski MJ; Lucchesi PA; Gooch KJ
Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H596-H608. PubMed ID: 30575422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
